Age at onset, mean (SD) (median), y |
60.69 (13.60) (60) |
58.91 (9.98) (59) |
0.501 |
Male, n (%) |
26 (74.29%) |
27 (58.7%) |
0.110 |
Female, n (%) |
9 (25.71%) |
19 (41.3%) |
|
Hepatic tumor location (for single lesion), n (%) |
18 (51.43%) |
23 (50%) |
0.539 |
III segment |
5 (14.29%) |
8 (17.39%) |
|
IV segment |
2 (5.71%) |
10 (21.74%) |
|
II segment |
4 (11.43%) |
3 (6.52%) |
|
Other segments |
7 (20%) |
2 (4.35%) |
|
Multifocal tumors, n (%) |
17 (48.57%) |
23 (50%) |
0.539 |
Tumor diameter, mean (median) (SD), cm |
6.73 (6) (4.62) |
6.93 (6.5) (4.08) |
0.840 |
Hepatic tumor load, mean (median) , cm3 |
211.1 (30) |
76.66 (35) |
0.036 |
Detection of regional lymph node metastases, n (%) |
10 (28.57%) |
4 (8.70%) |
0.020 |
Portal vein tumor thrombus, n (%) |
|
|
0.001 |
Positive |
32 (91.43%) |
35 (76.09%) |
|
Negative |
3 (8.57%) |
11 (23.91%) |
|
Extra organ invasion at diagnosis, n (%) |
6 (17.14%) |
4 (8.70%) |
0.210 |
Gall bladder |
1 |
2 |
|
Posterior peritoneum |
2 |
0 |
|
Lung |
2 |
1 |
|
Spleen |
1 |
0 |
|
Pancreas |
0 |
1 |
|
Necrosis, n (%) |
11 (31.43%) |
5 (10.87%) |
0.022 |
Tumor texture, n (%) |
|
|
0.602 |
Soft |
1 (2.94%) |
2 (4.35%) |
|
Hard |
34 (97.06%) |
44 (95.65%) |
|
WHO grade, n (%) |
|
|
0.564 |
G1 |
2 (5.71%) |
2 (4.34%) |
|
G2 |
7 (20%) |
14 (30.43%) |
|
G3 |
26 (74.29%) |
30 (65.23%) |
|
Tumor differentiation, n (%) |
|
|
0.070 |
Well-differentiated |
5 (14.29%) |
4 (8.70%) |
|
Moderately-differentiated |
21 (60%) |
21 (45.65%) |
|
Poorly-differentiated |
9 (25.71%) |
21 (45.65%) |
|
Ki-67 index, mean (SD) (median) |
26.80 (20.62) (21) |
22.20 (16.25) (20.50) |
0.264 |
Mitotic count, mean (SD) (median) |
6.54 (5.10) (5) |
8.54 (6.49) (8) |
0.137 |